October 2006


Sanofi-Aventis, A French pharmaceutical company, informed regulatory obstacles for the approval of potential blockbuster drug Acomplia and not set any time duration to launch anti-obesity drug Acomplia in United states because of waiting approval from FDA (Food and Drug Administration) for sales in US.
According to the Wednesday report the number of canadians people who are receiving hip and knee replacements surgeries increses upto 87 percent over the last 10 years.
According to the USA report, the study presented in the meeting of Obesity Society in Boston suggest that water is useful in weight loss and low fat foods may hinder it.
Resent research shows that sleep apnea is very complicated for those patients who go for surgery to solve the situation. Sleep apnea can create night awakening problem.
According to the health specialists every fifth child in Bulgaria is overweight and near about 50% of kids already facing the problem at the age of 18 and nearly 20 % of young women under the age of 30 faces the problem of underweight which is also a big problem.